When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BLUE - bluebird bio: Ticker Fueled By Gambling Chance Of Commercial Success
bluebird bio Inc.
BLUE is left with a troubled portfolio with low chances of commercial success, rendering the ticker a speculative trade.
The European Medicine Agency's "EMA" decision to authorize two of BLUE's therapies signals higher chances that its portfolio (3 drugs) will receive FDA authorization.
The company might generate capital gains fueled by gambling chances of profitability, but fundamentally, I don't see the company succeeding in the long term.